LAURA GARFINE: Open Payments
NPI 1487413274 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $144 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $169 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Exact Sciences Corporation | 1 | $33 |
| Ethicon US, LLC | 1 | $32 |
| Biogen, Inc. | 1 | $25 |
| Organon LLC | 1 | $21 |
| Seqirus USA Inc | 1 | $18 |
| Becton, Dickinson and Company | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Veozah, Cologuard Collection Kit, STRATAFIX, ZURZUVAE, Lynkuet, NEXPLANON, Mirena, Flucelvax.
Industry payments across CA — which companies pay providers there.
